SILK ROAD MEDICAL INC (SILK)
US82710M1009 - Common Stock
Commit To Buy Silk Road Medical At $12.50, Earn 13.6% Annualized Using Options
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
SUNNYVALE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its...
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of its ENROUTE® Transcarotid Neuroprotection System PLUS (“NPS PLUS”), a key component of the TCAR® portfolio. This next generation device builds upon the prior ENROUTE Transcarotid Neuroprotection System to deliver smoother arterial sheath insertion, greater flow precision, and a simplified prep experience for surgical teams, all while maintaining unparalleled neuroprotection during the TCAR procedure.
Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China
/PRNewswire/ -- Silk Road Medical (NASDAQ: SILK), a medical device company based in California USA and Genesis MedTech Group have signed an exclusive...
Thursday 3/7 Insider Buying Report: SLRC, SILK
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its...
Silk Road Medical GAAP EPS of -$0.33 beats by $0.06, revenue of $47.27M beats by $5.26M (NASDAQ:SILK)
Silk Road Medical beats expectations with Q4 earnings, reporting an 18% YoY revenue increase and projecting a strong revenue range for 2024.
SILK Makes Bullish Cross Above Critical Moving Average
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
SUNNYVALE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its...
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
SUNNYVALE, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its...
Notable Monday Option Activity: VZ, KAMN, SILK
Silk Road Medical stock gains as Stifel upgrades (NASDAQ:SILK)
Silk Road Medical (SILK) stock trades higher after Stifel raises recommendation to Buy and increases price target citing CEO's compelling remarks. Read more here.
Commit To Buy Silk Road Medical At $12.50, Earn 38.5% Annualized Using Options
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SUNNYVALE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its...
Monday Sector Leaders: Medical Instruments & Supplies, Cigarettes & Tobacco Stocks
Silk Road Medical GAAP EPS of $0.33 beats by $0.67, revenue of $44.4M beats by $0.06M (NASDAQ:SILK)
Silk Road Medical press release (NASDAQ:SILK): Q3 GAAP EPS of $0.33 beats by $0.67.Revenue of $44.4M (+18.7% Y/Y) beats by $0.06M.Projects revenue for full...
Silk Road Medical Reports Third Quarter 2023 Financial Results
Silk Road Medical Reports Third Quarter 2023 Financial Results
SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such...
Silk Road Medical appoints Chas McKhann as its CEO (NASDAQ:SILK)
Silk Road Medical names Chas McKhann as new CEO, replacing Erica Rogers who retired.
Silk Road Medical Names Chas McKhann Chief Executive Officer
Accomplished Leader with Over 25 Years of Medical Device Industry Experience